Breaking News Instant updates and real-time market news.

TEVA

Teva

$19.12

0.31 (1.65%)

07:37
02/13/19
02/13
07:37
02/13/19
07:37

Teva down 11% to $16.98 after FY19 guidance misses estimates

  • 13

    Feb

TEVA Teva
$19.12

0.31 (1.65%)

01/23/19
01/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman citing his belief that Walmart U.S. can now generate sales growth without sacrificing margins, unlike most retailers. 2. Teva (TEVA) upgraded to Buy from Neutral at UBS and to Neutral from Underweight at Piper Jaffray. 3. D.R. Horton (DHI) upgraded to Buy from Neutral at Mizuho with analyst Haendel St. Juste saying stock selectivity is becoming more important in these latter stages of the housing cycle and larger platforms with price point diversification and strong balance sheets will be rewarded. 4. Logitech (LOGI) upgraded to Overweight from Neutral at JPMorgan and to Hold from Sell at Maxim. 5. Lamb Weston (LW) upgraded to Buy from Hold at Stifel with analyst Christopher Growe saying he is confident in the "growth profile of the business continuing amidst the very strong operating conditions in the category." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/25/19
PIPR
01/25/19
NO CHANGE
PIPR
Report that CVS excluded Amgen's Aimovig 'greatly exaggerated,' says Piper
Piper Jaffray analyst Christopher Raymond kept an Overweight rating and $220 price target on Amgen (AMGN) following a Reuters report from earlier on Friday which stated that CVS (CVS) has excluded Amgen's Aimovig from its formulary. The analyst called the report "Friday afternoon clickbait" and noted that while CVS currently provides preferred status to Teva's (TEVA) Ajovy and Eli Lilly's (LLY) Emgality, this was made public in late 2018. In a check with management, Raymond found out the decision only encompasses about one-third of CVS network, that CVS is actively working to improve this access, and that 70% of commercial migraine patients have contracted access to Aimovig. Raymond concluded that this was "not something to worry about" in his view, and did not change his Q4, FY19, or FY20 estimates on Aimovig. In Friday trading, shares of Amgen were down just over 1% to $198.77.
01/30/19
WELS
01/30/19
NO CHANGE
WELS
Wells says Novartis report read-through 'neutral to negative' for Mylan, Teva
After Novartis' (NVS) Sandoz generics unit reported Q4 sales were down 2% in constant currency, due to a 7% decline in price and 5% increase in volume, Wells Fargo analyst David Maris noted that the majority of the price erosion came from the U.S. While the 2% decline was a sequential improvement from down 4% in Q3, Novartis was up against an easy comparison in the year ago period, Maris added. His view is that the U.S. generic market has not materially changed or improved at this point and he contends the report has a "neutral to negative read-through" relative to investors' expectations for Mylan (MYL) and Teva (TEVA).
02/01/19
WELS
02/01/19
NO CHANGE
Target $46
WELS
Market Perform
Perrigo's ProAir opportunity 'may be vaporizing,' says Wells Fargo
Wells Fargo analyst David Maris noted that GlaxoSmithKline (GSK) launched an authorized generic of Ventolin on January 15 and he has now learned that Teva (TEVA) may have "surprisingly launched" an authorized generic of ProAir in response to the generic Ventolin pressure prior to Perrigo's (PRGO) approval. Pricing pressure from generic Ventolin, in addition to the launch of an authorized generic well ahead of Perrigo's own generic ProAir launch, seem to have significantly diminished Perrigo's generic ProAir opportunity, Maris tells investors. He keeps a Market Perform rating and $46 price target on Perrigo shares.

TODAY'S FREE FLY STORIES

LBY

Libbey

$5.75

0.15 (2.68%)

18:13
02/20/19
02/20
18:13
02/20/19
18:13
Earnings
Libbey reports Q4 EPS (18c), two estimates 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:07
02/20/19
02/20
18:07
02/20/19
18:07
Hot Stocks
NetEase reports Q4 online game service revenues up 37.7% at $1.6B »

Reports Q4 e-commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:05
02/20/19
02/20
18:05
02/20/19
18:05
Hot Stocks
NetEase declares Q4 quarterly dividend of 48c vs 45c in Q3 »

The dividend is expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

NTES

NetEase

$232.66

3.11 (1.35%)

18:04
02/20/19
02/20
18:04
02/20/19
18:04
Earnings
NetEase reports Q4 EPS $2.66, consensus $1.54 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

LEE

Lee Enterprises

$2.61

0.01 (0.38%)

18:04
02/20/19
02/20
18:04
02/20/19
18:04
Hot Stocks
Lee Enterprises board approves $10M stock repurchase program »

Lee Enterprises announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNY

Kearny Financial

$13.48

-0.01 (-0.07%)

18:03
02/20/19
02/20
18:03
02/20/19
18:03
Hot Stocks
Kearny Financial raises quarterly dividend to 6c per share from 5c »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$53.43

0.11 (0.21%)

18:02
02/20/19
02/20
18:02
02/20/19
18:02
Earnings
Breaking Earnings news story on Copart »

Copart reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

CE

Celanese

$102.65

1.71 (1.69%)

18:02
02/20/19
02/20
18:02
02/20/19
18:02
Hot Stocks
Celanese raises Acetyl Intermediates price by 5c per lb »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$53.43

0.11 (0.21%)

18:01
02/20/19
02/20
18:01
02/20/19
18:01
Earnings
Copart reports Q2 EPS 55c, consensus 51c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

WPG

Washington Prime

$5.77

(0.00%)

17:50
02/20/19
02/20
17:50
02/20/19
17:50
Earnings
Breaking Earnings news story on Washington Prime »

Washington Prime sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CPA

Copa Holdings

$89.89

-0.8 (-0.88%)

, GE

General Electric

$10.10

-0.03 (-0.30%)

17:49
02/20/19
02/20
17:49
02/20/19
17:49
Hot Stocks
Copa Airlines picks GE Aviation for digital records management »

Copa Airlines (CPA) has…

CPA

Copa Holdings

$89.89

-0.8 (-0.88%)

GE

General Electric

$10.10

-0.03 (-0.30%)

BA

Boeing

$421.61

5.21 (1.25%)

ERJ

Embraer

$20.52

-0.14 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Feb

  • 11

    Mar

  • 12

    Mar

  • 14

    Mar

  • 28

    May

WPG

Washington Prime

$5.77

(0.00%)

17:49
02/20/19
02/20
17:49
02/20/19
17:49
Earnings
Washington Prime reports Q4 AFFO 38c, one estimate 39c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

RMAX

RE/MAX Holdings

$40.54

0.11 (0.27%)

17:48
02/20/19
02/20
17:48
02/20/19
17:48
Hot Stocks
RE/MAX Holdings raises quarterly dividend 5% to 21c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 08

    Mar

  • 13

    Mar

MSA

MSA Safety

$100.06

-1.13 (-1.12%)

17:46
02/20/19
02/20
17:46
02/20/19
17:46
Earnings
MSA Safety reports Q4 adjusted EPS $1.27, consensus $1.27 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TFX

Teleflex

$286.65

4.57 (1.62%)

, PINC

Premier

$38.05

-0.03 (-0.08%)

17:31
02/20/19
02/20
17:31
02/20/19
17:31
Hot Stocks
Teleflex awarded SURPASS deal with Premier »

Teleflex (TFX) has been…

TFX

Teleflex

$286.65

4.57 (1.62%)

PINC

Premier

$38.05

-0.03 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

  • 03

    Mar

  • 06

    Mar

AGI

Alamos Gold

$4.87

0.05 (1.04%)

17:31
02/20/19
02/20
17:31
02/20/19
17:31
Earnings
Alamos Gold reports Q4 adjusted EPS 1c, consensus 6c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NTR

Nutrien

$54.43

1.075 (2.02%)

17:30
02/20/19
02/20
17:30
02/20/19
17:30
Hot Stocks
Nutrien intends to renew share repurchase program »

Nutrien announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 27

    Feb

AKRX

Akorn

$4.03

-0.42 (-9.44%)

, FSNUY

Fresenius SE

$0.00

(0.00%)

17:28
02/20/19
02/20
17:28
02/20/19
17:28
Hot Stocks
Akorn 'strongly contests' Fresenius' proposed amended claims »

Akorn, Inc. (AKRX) said…

AKRX

Akorn

$4.03

-0.42 (-9.44%)

FSNUY

Fresenius SE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 01

    May

MESO

Mesoblast

$4.28

0.13 (3.13%)

17:26
02/20/19
02/20
17:26
02/20/19
17:26
Earnings
Mesoblast reports 1H19 $44.1M loss versus 1H18 profit of $6.7M »

In the first half FY2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

KODK

Kodak

$3.03

-0.045 (-1.47%)

17:21
02/20/19
02/20
17:21
02/20/19
17:21
Hot Stocks
Kodak names Jim Continenza executive chairman »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$43.17

-0.2 (-0.46%)

17:20
02/20/19
02/20
17:20
02/20/19
17:20
Hot Stocks
Macquarie Infrastructure sees FY19 EBITDA $610M-$635M vs. $601.9M last year »

Sees FY19 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MIC

Macquarie Infrastructure

$43.17

-0.2 (-0.46%)

17:19
02/20/19
02/20
17:19
02/20/19
17:19
Earnings
Macquarie Infrastructure reports Q4 adj. EBITDA $152.4M vs. $159.6M last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CAKE

Cheesecake Factory

$46.42

-0.07 (-0.15%)

17:16
02/20/19
02/20
17:16
02/20/19
17:16
Hot Stocks
Breaking Hot Stocks news story on Cheesecake Factory »

Cheesecake Factory sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 06

    Mar

CAKE

Cheesecake Factory

$46.42

-0.07 (-0.15%)

17:16
02/20/19
02/20
17:16
02/20/19
17:16
Earnings
Cheesecake Factory sees Q1 adjusted EPS 58c-62c, consensus 61c »

Guidance taken from Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 06

    Mar

HTBK

Heritage Commerce

$14.17

0.17 (1.21%)

17:15
02/20/19
02/20
17:15
02/20/19
17:15
Hot Stocks
Heritage Commerce director Robert Moles sells almost 50K shares »

Heritage Commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.